Literature DB >> 11036280

Endoscopic management of polypoid early colon cancer.

C B Williams1, B P Saunders, I C Talbot.   

Abstract

Endoscopic management of polypoid early colonic cancer (malignant polyps and polypoid carcinomas) is no longer controversial. When the endoscopist is satisfied that excision is complete and histology is "favorable" (a resection margin of 2 mm and well or moderately well differentiated tumor), surgery is unnecessary. When histology show "unfavorable" characteristics (which a few histologists still take to include invasion into lymphatics), surgical or laparoscopic resection may be indicated, providing the patient is considered at suitable risk. Surgery kills some patients without finding residual cancer and cannot save others with metastases, so it should be recommended only with due clinical consideration. Sessile or broad-based polyps, especially those in the rectum, are more likely to be "high risk" and merit specialist management if local removal is to be attempted and to allow proper histologic assessment. Endoscopic approaches such as saline injection polypectomy, india-ink tattooing, and use of the argon beam coagulator are applicable in some cases. New approaches that still require trials include ultrasonographic probes, which occasionally clarify the degree of invasion, and prototype stapling devices to allow full-thickness histologic specimens to be obtained.

Entities:  

Mesh:

Year:  2000        PMID: 11036280     DOI: 10.1007/s002680010144

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  7 in total

1.  Multicentric GISCoR Study "intensive clinical follow-up versus surgical radicalization after complete endoscopic polypectomy of a malignant adenoma" (SEC-GISCoR).

Authors:  Bruno Andreoni; Lorenzo Camellini; Angelica Sonzogni; Cristiano Crosta; Maria Elena Pirola; Carlo Corbellini
Journal:  Updates Surg       Date:  2011-06-07

Review 2.  Assessment and management of the malignant colorectal polyp.

Authors:  Laura J Neilson; Matthew D Rutter; Brian P Saunders; Andrew Plumb; Colin J Rees
Journal:  Frontline Gastroenterol       Date:  2015-03-06

3.  Management of the malignant polyp.

Authors:  Marcela Ramirez; Steven Schierling; Harry T Papaconstantinou; J Scott Thomas
Journal:  Clin Colon Rectal Surg       Date:  2008-11

4.  Histological factors contributing to a high risk of recurrence of submucosal invasive cancer (pT1) of the colon and rectum after endoscopic therapy.

Authors:  Ichiro Nakada; Takanobu Tabuchi; Takeshi Nakachi; Jiro Shimazaki; Satoru Konishi; Motonobu Katano; Hideyuki Ubukata; Yoshihisa Goto; Yoshinori Watanabe; Takafumi Tabuchi
Journal:  Surg Today       Date:  2008-07-31       Impact factor: 2.549

Review 5.  Clear cell adenocarcinoma of the colon: a case report and review of literature.

Authors:  Koichi Soga; Hideyuki Konishi; Natsuko Tatsumi; Chika Konishi; Keimei Nakano; Naoki Wakabayashi; Shoji Mitsufuji; Keisho Kataoka; Takeshi Okanoue; Ken-Ichi Mukaisho; Takanori Hattori
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

6.  Conventional endoscopic features are not sufficient to differentiate small, early colorectal cancer.

Authors:  Wan Park; Bun Kim; Soo Jung Park; Jae Hee Cheon; Tae Il Kim; Won Ho Kim; Sung Pil Hong
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

7.  Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2.

Authors:  S Kazama; T Watanabe; Y Ajioka; T Kanazawa; H Nagawa
Journal:  Br J Cancer       Date:  2006-01-30       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.